Dorval, Quebec–(Newsfile Corp. – June 28, 2022) – West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTC Pink: WIBFF) (“West Island” or the “Company”) is pleased to announce that further to our news release of January 17, 2022, West Island’s subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A West Island Culture has forwarded its first shipments cannabis products to the Province of Quebec.
West Island has been approved for a general listing of four SKUs in by the Société Québécoise Du Cannabis (the “SQDC”):
West Island CEO, Boris Ziger states, “West Island is thrilled to finally be in its home province of Quebec. Since the success of CITIZEN™ and our premium brands OUEST™ of craft cannabis in other parts of Canada, we can’t wait to bring them home. We expect Quebec to be one of our biggest markets in Canada, which makes it a very important step in the development of the company.”
About West Island
West Island is a multi-faceted, innovative company in the Quebec cannabis space. Its subsidiary, RoyalMax Biotechnology Canada Inc. is a Dorval, Quebec based Health Canada Licence Holder with standard cultivation licence, standard processing, medical sales and sales licences. The Company continues to work with Yunify Natural Technologies, a Quebec based health and personal care research and innovation company to develop proprietary products for West Island including topicals and ionic mists. Through its acquisition of Trichome Treats, an award-winning chocolatier, the Company intends on introducing edibles into the West Island product mix.
For more information on West Island Brands please visit the website at: westislandbrands.com.
On behalf of the Board of Directors
WEST ISLAND BRANDS INC.
Boris Ziger
Boris Ziger, CEO & Chairman
The Company’s public filings are available for review at www.sedar.com and www.thecse.com.
For further information, please contact:
Boris Ziger, CEO at:
Telephone: 416-304-9935
E-mail: info@westislandbrands.com
Website: www.westislandbrands.com
Boris Ziger, PDG de :
Téléphone : 416-304-9935
Courriel : info@westislandbrands.com
Site Web : www.westislandbrands.com
Disclaimer for Forward-Looking Information
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/129208
- Revenue increase of over 600%Dallas, Georgia--(Newsfile Corp. - July 2, 2024) - Bemax Inc.…
VANCOUVER, BC / ACCESSWIRE / July 2, 2024 / 1933 Industries Inc. (the "Company" or…
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a…
SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a…
The ceremony will be held in celebration of Scilex’s launch of GLOPERBA®, an innovative non-opioid…
July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG…